SFV HEALTHCARERecent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
Medical-device maker Medtronic on Wednesday announced that it has entered into an international, multi-year contract with mobile tech company Qualcomm Inc., a subsidiary of San Diego-based Qualcomm Life Inc., to collaboratively develop future models of its continuous glucose monitoring systems.
A subsidiary of Amgen Inc. has discovered a rare variation in the sequence of a human gene that gives people a significant reduction in levels of “bad” cholesterol and lowers the risk of heart attacks, the company announced Wednesday.
The Matrix Institute on Addictions has appointed Dr. Kenji Watanabe as clinical director for its Woodland Hills facility.
Providence Tarzana Medical Center on Thursday announced a $624 million expansion plan that calls for a new patient wing including a lobby and reception area as well as new diagnostic and treatment areas and expanded parking.
Cigna Corp. on Wednesday announced that it has entered into an agreement with Thousand Oaks biotech Amgen Inc. that will directly tie the price the insurance company will pay for a pricey new cholesterol drug to its effectiveness on individual patients.
MannKind Corp.’s stock dropped nearly 28 percent on Tuesday, the day after the company reported its first quarter financial results followed by a conference call that never mentioned a stock dilution that was announced shortly after.
MannKind Corp. on Monday announced its first quarter financial results, narrowing its net loss but missing analysts’ expectations.
Amgen Inc. reportedly is considering a bid to purchase cancer therapy company Medivation Inc. of San Francisco.
Sienna Biopharmaceuticals Inc. of Westlake Village on Friday announced that it has completed a Series A financing that raised $34 million.
Second Sight Medical Products Inc. has reported a bigger loss in its first quarter.
Amgen Inc. on Thursday reported first-quarter financial results that exceeded Wall Street’s expectations.
Abbott Laboratories of Abbott Park, Ill. on Thursday announced it will spend $19.3 billion to buy St. Jude Medical Inc. of St. Paul, Minn., a medical device company with a large manufacturing facility in Sylmar.
Valley Presbyterian Hospital has announced that it received a $250,000 grant from the Henry L. Guenther Foundation, which will go toward the hospital’s $8.4 million project to expand its emergency department.
Ceres Inc. has secured two patents for genetic plant traits that can help increase crop yields, the company announced Tuesday.
A Phase 3 study has shown that Amgen Inc.’s drug Nplate helped a majority of children with a bleeding disorder called immune thrombocytopenia, the company announced Wednesday.